Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × Transitional Cell Carcinoma of Ureter × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 126 Carcinoma, Non-Small-Cell Lung 91 Colorectal Neoplasms 82 Carcinoma, Hepatocellular 66 Stomach Neoplasms 60 Rectal Neoplasms 48 Neoplasms 47 Lung Neoplasms 43 Nasopharyngeal Carcinoma 38 Leukemia, Myeloid, Acute 37 Lymphoma, Large B-Cell, Diffuse 36 Colonic Neoplasms 36 Prostatic Neoplasms 33 Neoplasm Metastasis 33 Uterine Cervical Neoplasms 32 Ovarian Neoplasms 29 Multiple Myeloma 29 Lymphoma, Follicular 29 Esophageal Neoplasms 29 Lymphoma 27 Pancreatic Neoplasms 26 Leukemia 26 Recurrence 22 Brain Neoplasms 20 Urinary Bladder Neoplasms 18 Lymphoma, Non-Hodgkin 18 Head and Neck Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Lymphoma, Mantle-Cell 16 Leukemia, Lymphocytic, Chronic, B-Cell 16

Interventions

Gemcitabine 1 Drug Therapy 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01993979 2020-05-04

POUT

Institute of Cancer Research, United Kingdom

Phase 3 Unknown

Transitional Cell Carcinoma of Ureter

Data powered by HemOnc (CC BY 4.0) Colophon ⚡